Tradition Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Tradition Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-75	Closed	-$3K	–	709
2023 Q4	$3K	Sell	75 -290	-79%	-$11.8K	﹤0.01%	1234
2023 Q3	$15K	Hold	365	–	–	﹤0.01%	921
2023 Q2	$18K	Hold	365	–	–	﹤0.01%	903
2023 Q1	$18K	Hold	365	–	–	﹤0.01%	853
2022 Q4	$18K	Buy	365 +115	+46%	+$5.93K	﹤0.01%	773
2022 Q3	$13K	Hold	250	–	–	﹤0.01%	864
2022 Q2	$12K	Hold	250	–	–	﹤0.01%	776
2022 Q1	$15K	Hold	250	–	–	﹤0.01%	793
2021 Q4	$20K	Buy	+250	New	+$21K	﹤0.01%	726

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Tradition Wealth Management's GNOM Position: Q1 2024 in Review

Tradition Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2024, closing a stake of 75 shares — an estimated $3K sold.

Tradition Wealth Management first reported a position in GNOM in Q4 2021 and held it in 9 quarters. The position peaked at $20K in Q4 2021. 59 funds tracked by Wall St. Rank hold GNOM as of Q1 2024.

Tradition Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
Tradition Wealth Management sold 75 Global X Genomics & Biotechnology ETF shares in Q1 2024, an estimated $3K.
Tradition Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and held it in 9 quarters.
Tradition Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $20K in Q4 2021.
59 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.